-
1
-
-
0034894477
-
Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre
-
Abe T, Ludecke DK: Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 145:137-145, 2001
-
(2001)
Eur J Endocrinol
, vol.145
, pp. 137-145
-
-
Abe, T.1
Ludecke, D.K.2
-
2
-
-
0031772696
-
Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results
-
Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418, 1998
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3411-3418
-
-
Abosch, A.1
Tyrrell, J.B.2
Lamborn, K.R.3
Hannegan, L.T.4
Applebury, C.B.5
Wilson, C.B.6
-
3
-
-
0023698506
-
Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: Shrinkage of invasive pituitary macroadenomas and improved surgical remission rate
-
Barkan AL, Lloyd RV, Chandler WF, Hatfield MK, Gebarski SS, Kelch RP, et al: Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab 67:1040-1048, 1988
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 1040-1048
-
-
Barkan, A.L.1
Lloyd, R.V.2
Chandler, W.F.3
Hatfield, M.K.4
Gebarski, S.S.5
Kelch, R.P.6
-
4
-
-
0037232613
-
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly
-
Beauregard C, Truong U, Hardy J, Serri O: Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86-91, 2003
-
(2003)
Clin Endocrinol (Oxf)
, vol.58
, pp. 86-91
-
-
Beauregard, C.1
Truong, U.2
Hardy, J.3
Serri, O.4
-
5
-
-
0023886723
-
Epidemiology and long-term survival in acromegaly: A study of 166 cases diagnosed between 1955 and 1984
-
Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B: Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327-335, 1988
-
(1988)
Acta Med Scand
, vol.223
, pp. 327-335
-
-
Bengtsson, B.A.1
Eden, S.2
Ernest, I.3
Oden, A.4
Sjogren, B.5
-
6
-
-
0037340306
-
Clinical Review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly
-
Ben-Shlomo A, Melmed S: Clinical Review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly. J Clin Endocrinol Metab 88:963-968, 2003
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 963-968
-
-
Ben-Shlomo, A.1
Melmed, S.2
-
7
-
-
0033305397
-
Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls
-
Biermasz NR, van Dulken H, Roelfsema E: Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls. J Clin Endocrinol Metab 84:3551-3555, 1999
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 3551-3555
-
-
Biermasz, N.R.1
Van Dulken, H.2
Roelfsema, E.3
-
8
-
-
0032956615
-
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly
-
Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, et al: Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. J Clin Endocrinol Metab 84:17-23, 1999
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 17-23
-
-
Colao, A.1
Cuocolo, A.2
Marzullo, P.3
Nicolai, E.4
Ferone, D.5
Florimonte, L.6
-
9
-
-
9844264858
-
Effect of octreotide pretreatment on surgical outcome in acromegaly
-
Colao A, Ferone D, Cappabianca P, del Basso De Caro ML, Marzullo P, Monticelli A, et al: Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 82:3308-3314, 1997
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 3308-3314
-
-
Colao, A.1
Ferone, D.2
Cappabianca, P.3
Del Basso De Caro, M.L.4
Marzullo, P.5
Monticelli, A.6
-
10
-
-
0034974291
-
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly
-
Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, et al: Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779-2786, 2001
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 2779-2786
-
-
Colao, A.1
Ferone, D.2
Marzullo, P.3
Cappabianca, P.4
Cirillo, S.5
Boerlin, V.6
-
11
-
-
0034578569
-
Lanreotide 60 mg, a longer-acting somatostatin analog: Tumor shrinkage and hormonal normalization in acromegaly
-
Cozzi R, Barausse M, Sberna M, Lodrini A, Franzini A, Lasio G, et al: Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly. Pituitary 3:231-238, 2000
-
(2000)
Pituitary
, vol.3
, pp. 231-238
-
-
Cozzi, R.1
Barausse, M.2
Sberna, M.3
Lodrini, A.4
Franzini, A.5
Lasio, G.6
-
12
-
-
0026787125
-
Octreotide treatment of acromegaly: A randomized multicenter study
-
Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, et al: Octreotide treatment of acromegaly: a randomized multicenter study. Ann Intern Med 117:711-718, 1992
-
(1992)
Ann Intern Med
, vol.117
, pp. 711-718
-
-
Ezzat, S.1
Snyder, P.J.2
Young, W.F.3
Boyajy, L.D.4
Newman, C.5
Klibanski, A.6
-
13
-
-
0027368949
-
Advances in the medical and surgical treatment of pituitary adenomas: The role of long-acting somatostatin analogs
-
Participants of the "Conference on Medical and Surgical Treatment of Pituitary Adenomas" (Zürich, 5th October, 1991)
-
Fahlbusch R, Giovanelli M, Buchfelder M, Losa M: Advances in the medical and surgical treatment of pituitary adenomas: The role of long-acting somatostatin analogs. Participants of the "Conference on Medical and Surgical Treatment of Pituitary Adenomas" (Zürich, 5th October, 1991). J Endocrinol Invest 16:449-460, 1993
-
(1993)
J Endocrinol Invest
, vol.16
, pp. 449-460
-
-
Fahlbusch, R.1
Giovanelli, M.2
Buchfelder, M.3
Losa, M.4
-
14
-
-
0036319414
-
Somatostatin analogs in acromegaly
-
Freda PU: Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 87:3013-3018, 2002
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3013-3018
-
-
Freda, P.U.1
-
15
-
-
0031782211
-
Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly
-
Freda PU, Wardlaw SL, Post KD: Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358, 1998
-
(1998)
J Neurosurg
, vol.89
, pp. 353-358
-
-
Freda, P.U.1
Wardlaw, S.L.2
Post, K.D.3
-
16
-
-
0029922510
-
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: Six-month report on an Italian multicenter study
-
Italian Multicenter Slow Release Lanreotide Study Group
-
Giusti M, Gussoni G, Cuttica CM, Giordano G: Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group. J Clin Endocrinol Metab 81:2089-2097, 1996
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 2089-2097
-
-
Giusti, M.1
Gussoni, G.2
Cuttica, C.M.3
Giordano, G.4
-
17
-
-
17744371632
-
Criteria for cure of acromegaly: A consensus statement
-
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, et al: Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529, 2000
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 526-529
-
-
Giustina, A.1
Barkan, A.2
Casanueva, F.F.3
Cavagnini, F.4
Frohman, L.5
Ho, K.6
-
18
-
-
0033562525
-
Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog)
-
Hradec J, Kral J, Janota T, Krsek M, Hana V, Marek J, et al: Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog). Am J Cardio l83:1506-1509, 1999
-
(1999)
Am J Cardiol
, vol.83
, pp. 1506-1509
-
-
Hradec, J.1
Kral, J.2
Janota, T.3
Krsek, M.4
Hana, V.5
Marek, J.6
-
19
-
-
0027450982
-
Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings
-
Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-618, 1993
-
(1993)
Neurosurgery
, vol.33
, pp. 610-618
-
-
Knosp, E.1
Steiner, E.2
Kitz, K.3
Matula, C.4
-
20
-
-
0032928394
-
Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study
-
Kristof RA, Stoffel-Wagner B, Klingmuller D, Schramm J: Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study. Acta Neurochir (Wien) 141:399-405, 1999
-
(1999)
Acta Neurochir (Wien)
, vol.141
, pp. 399-405
-
-
Kristof, R.A.1
Stoffel-Wagner, B.2
Klingmuller, D.3
Schramm, J.4
-
21
-
-
0028111363
-
Improvement of sleep apnoea due to acromegaly during short-term treatment with octreotide
-
Leibowitz G, Shapiro MS, Salameh M, Glasser B: Improvement of sleep apnoea due to acromegaly during short-term treatment with octreotide. J Intern Med 236:231-235, 1994
-
(1994)
J Intern Med
, vol.236
, pp. 231-235
-
-
Leibowitz, G.1
Shapiro, M.S.2
Salameh, M.3
Glasser, B.4
-
22
-
-
0033888471
-
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: Comparison between micro-and macroadenomas
-
Losa M, Barzaghi RL, Mortini P, Franzin A, Mangili F, Terreni MR, et al: Determination of the proliferation and apoptotic index in adrenocorticotropin- secreting pituitary tumors: comparison between micro-and macroadenomas. Am J Pathol 156:245-251, 2000
-
(2000)
Am J Pathol
, vol.156
, pp. 245-251
-
-
Losa, M.1
Barzaghi, R.L.2
Mortini, P.3
Franzin, A.4
Mangili, F.5
Terreni, M.R.6
-
23
-
-
17944371979
-
Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas
-
Losa M, Ciccarelli E, Mortini P, Barzaghi R, Gaia D, Faccani G, et al: Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas. J Clin Endocrinol Metab 86:5194-5200, 2001
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 5194-5200
-
-
Losa, M.1
Ciccarelli, E.2
Mortini, P.3
Barzaghi, R.4
Gaia, D.5
Faccani, G.6
-
24
-
-
0033376774
-
Is presurgical treatment with somatostatin analogs necessary in acromegalic patients?
-
Losa M, Mortini P, Giovanelli M: Is presurgical treatment with somatostatin analogs necessary in acromegalic patients? J Endocrinol Invest 22:871-873, 1999
-
(1999)
J Endocrinol Invest
, vol.22
, pp. 871-873
-
-
Losa, M.1
Mortini, P.2
Giovanelli, M.3
-
25
-
-
0028276296
-
Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery
-
Lucas-Morante T, Garcia-Uria J, Estrada J, Saucedo G, Cabello A, Alcaniz J, et al: Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery. J Neurosurg 81:10-14, 1994
-
(1994)
J Neurosurg
, vol.81
, pp. 10-14
-
-
Lucas-Morante, T.1
Garcia-Uria, J.2
Estrada, J.3
Saucedo, G.4
Cabello, A.5
Alcaniz, J.6
-
26
-
-
18544363593
-
Guidelines for acromegaly management
-
Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, et al: Guidelines for acromegaly management. J Clin Endocrinol Metab 87:4054-4058, 2002
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4054-4058
-
-
Melmed, S.1
Casanueva, F.F.2
Cavagnini, F.3
Chanson, P.4
Frohman, L.5
Grossman, A.6
-
27
-
-
20044372351
-
Results of transsphenoidal surgery in a large series of patients with pituitary adenoma
-
Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M: Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56:1222-1233, 2005
-
(2005)
Neurosurgery
, vol.56
, pp. 1222-1233
-
-
Mortini, P.1
Losa, M.2
Barzaghi, R.3
Boari, N.4
Giovanelli, M.5
-
28
-
-
7844232389
-
Octreotide as primary therapy for acromegaly
-
Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, et al: Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 83:3034-3040, 1998
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3034-3040
-
-
Newman, C.B.1
Melmed, S.2
George, A.3
Torigian, D.4
Duhaney, M.5
Snyder, P.6
-
29
-
-
0031759850
-
Mortality and cancer incidence in acromegaly: A retrospective cohort study
-
United Kingdom Acromegaly Study Group
-
Orme SM, McNally RJQ, Cartwright RA, Belchetz PE: Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730-2734, 1998
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 2730-2734
-
-
Orme, S.M.1
McNally, R.J.Q.2
Cartwright, R.A.3
Belchetz, P.E.4
-
30
-
-
0028135581
-
Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effects on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy
-
Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ: Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effects on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J Clin Endocrinol Metab 79:1416-1423, 1994
-
(1994)
J Clin Endocrinol Metab
, vol.79
, pp. 1416-1423
-
-
Plöckinger, U.1
Reichel, M.2
Fett, U.3
Saeger, W.4
Quabbe, H.J.5
-
31
-
-
0034758922
-
Treatment guidelines for acromegaly. Report from a Scandinavian workshop: First Scandinavian Workshop on the Treatment of Acromegaly
-
Scandinavian Workshop on the Treatment of Acromegaly
-
Scandinavian Workshop on the Treatment of Acromegaly: Treatment guidelines for acromegaly. Report from a Scandinavian workshop: first Scandinavian Workshop on the Treatment of Acromegaly. Growth Horm IGF Res 11:72-74, 2001
-
(2001)
Growth Horm IGF Res
, vol.11
, pp. 72-74
-
-
-
32
-
-
0033917672
-
Difficult intubation in acromegalic patients: Incidence and predictability
-
Schmitt H, Buchfelder M, Radespiel-Troger M, Fahlbusch R: Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology 93:110-114, 2000
-
(2000)
Anesthesiology
, vol.93
, pp. 110-114
-
-
Schmitt, H.1
Buchfelder, M.2
Radespiel-Troger, M.3
Fahlbusch, R.4
-
33
-
-
0033977602
-
Anaesthetic complications of acromegaly
-
Seidman PA, Kofke WA, Policare R, Young M: Anaesthetic complications of acromegaly. Br J Anaesth 84:179-182, 2000
-
(2000)
Br J Anaesth
, vol.84
, pp. 179-182
-
-
Seidman, P.A.1
Kofke, W.A.2
Policare, R.3
Young, M.4
-
34
-
-
0023133797
-
Preoperative treatment of 5 acromegalics with a somatostatin analogue: Endocrine and clinical observations
-
Spinas GA, Zapf J, Landolt AM, Stuckmann G, Froesch ER: Preoperative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations. Acta Endocrinol (Copenh) 114:249-256, 1987
-
(1987)
Acta Endocrinol (Copenh)
, vol.114
, pp. 249-256
-
-
Spinas, G.A.1
Zapf, J.2
Landolt, A.M.3
Stuckmann, G.4
Froesch, E.R.5
-
35
-
-
0029786231
-
Presurgical octreotide: Treatment in acromegaly
-
Stevenaert A, Beckers A: Presurgical octreotide: treatment in acromegaly. Metabolism 45 (8 Suppl 1):72-74, 1996
-
(1996)
Metabolism
, vol.45
, Issue.8 SUPPL. 1
, pp. 72-74
-
-
Stevenaert, A.1
Beckers, A.2
-
36
-
-
0028864383
-
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly
-
Stewart PM, Kane KF, Stewart SE, Lancranjan I, Sheppard MC: Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly. J Clin Endocrinol Metab 80:3267-3272, 1995
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 3267-3272
-
-
Stewart, P.M.1
Kane, K.F.2
Stewart, S.E.3
Lancranjan, I.4
Sheppard, M.C.5
-
37
-
-
0031774361
-
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly
-
Swearingen B, Barker FG II, Katznelson L, Biller BM, Grinspoon S, Klibanski A, et al: Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426, 1998
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3419-3426
-
-
Swearingen, B.1
Barker II, F.G.2
Katznelson, L.3
Biller, B.M.4
Grinspoon, S.5
Klibanski, A.6
|